Skip to main content

Healthcare overhaul promotes testing of ways to give hospitals more clout over prices

By Wall Street Journal  
   May 17, 2010

The U.S. healthcare overhaul could help hospitals cut costs for high-priced medical devices, raising a long-term risk for manufacturers already facing some pressure on product prices, the Wall Street Journal reports. Hospitals lack leverage when negotiating prices for high-cost implants because individual doctors, rather than hospitals, typically select the products they use in their patients. Since these doctors often aren't hospital employees, they have little incentive to bargain-hunt. New health rules, however, call for more testing of ways to bring doctors' financial interests more in line with those of hospitals.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.